Start with understanding.
Explore the learning center and discuss stocks, options, news, and risk with other members.
Stocks. Options. A better conversation.
Research stocks and options with people who share your curiosity. Stock Market Chat combines a free trading Discord, market news, education, and proprietary research tools in one community.
Already a member? Open your market workspace
Research with more context
Explore company news, overnight price activity, options positioning, and valuation with research tools built by Stock Market Chat.
Follow the market beyond the regular session.
Read the overviewKeep company announcements close to the conversation.
Read the overviewA dedicated view of notable options sweep activity.
Read the overviewAdd gamma-exposure context to your market research.
Read the overviewResearch how market leadership is changing.
Read the overviewExplore the expectations behind a stock's valuation.
Read the overviewMore than a signals server
Ask questions, compare perspectives, and understand the reasoning behind an idea. Bring your curiosity whether you are making your first watchlist or refining years of experience.
Get to know the community →Explore the learning center and discuss stocks, options, news, and risk with other members.
Follow market updates and customize the notifications that matter to you.
Join the stock market games, follow weekly and monthly rankings, and share the experience.
Find your place at SMC
Start here
A place for traders and investors to learn, share perspectives, and follow the market together.
Go deeper
Support the community and explore advanced proprietary research through an optional Patreon membership.
Check Patreon for current tiers, pricing, and included benefits.
Latest from SMC Research
Read recent company developments with direct source links, clearly separated context, and visible uncertainty.
Confirmed — Bristol Myers Squibb (BMY) and BioNTech published Phase 2 results for pumitamig in advanced non–small cell lung cancer (after progression on immunotherapy plus chemotherapy), reporting efficacy readouts and a manageable safety profile; BMY is showing confirmed news flow and elevated after‑hours activity in SMC data.
Confirmed — Rithm Capital (RITM) published third‑quarter 2026 results (Oct. 23, 2026): revenue $1.76B, net income $217.1M and EPS $0.38; an earnings call is live. Traders: this is a company-level earnings release and a structured trading-event candidate — watch price, volume and company filings for confirmation.
MARKET NEWS
SPY closed up +0.117%, QQQ +0.167% and IWM +0.131% on the most recent completed session. The headline indexes moved only modestly while activity concentrated in confirmed news runners, high relative‑volume movers and several high‑short‑interest/short‑squeeze signatures; options flow showed put concentration in semiconductors (notably MU and NVDA). Source: SMC Research.
A few useful answers
Yes. The Discord community is free to join. An optional Patreon membership provides advanced subscriber research and helps support SMC.
Subscriber market data, research outputs, and alerts are delivered in the Stock Market Chat Discord. Connect your Discord account to Patreon and complete the server's verification.
Absolutely. Start with the educational resources, ask questions, and learn through the community. You do not need to be an experienced trader.
Join the Discord server and complete verification, then sign in with that same Discord account to access the member workspace.
Start with the community
Join free. Get to know SMC. Explore advanced research when you are ready.